ELIQUIS SPRINKLE
- Product NDC
- 0003-0898
- 11-digit product format
- 000030898
- Labeler code
- 0003
- Product ID
- 0003-0898_f96cb5ea-74e9-4751-883d-d18ef0d83640
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- apixaban
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Application
- NDA220073
- Marketing category
- NDA
- Marketing start
- 2025-09-15
- Substance
- APIXABAN
- Active strength
- .15 mg/1
- Pharmacologic classes
- Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ELIQUIS SPRINKLE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| APIXABAN | .15 mg/1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0003-0898-28 | 00003089828 | 28 CAPSULE in 1 BOTTLE (0003-0898-28) | 28 capsule | 2025-09-15 | No | No | Current |